Skip to content

Effect of homoeopathic medicine on treatment of anaemia

To evaluate the efficacy of antipsoric individualized homoeopathic medicines in lm potencies, in cases of iron deficiency anaemia among 12-60 years age group: a single-blind randomized placebo-control trial - NONE

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075331
Enrollment
60
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50- Iron deficiency anemia

Interventions

Intervention1: Individualised homoeopathic medicines of antipsoric group: Antipsoric group homoeopathic medicines will be administed as per signs and symptoms of each patient. 4 single medicated cane
14 equal doses are to be marked on the phial. Each dose of 5 ml to be taken into normal water in a clean cup after 10 uniformly downward strokes on the phial each time.Only 5 ml from this cup will be
14doses to be marked on the vial. Each identical-looking, non-medicated dose of 5 ml to be taken into normal water in a clean cup after 10 uniformly downward strokes on the phial each time.Only 5 ml f

Sponsors

Metropolitan Homoeopathic Medical College & Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Persons have been Clinically diagnosed with iron deficiency anaemia. 2) Diagnosis should be confirmed by laboratory investigation such as haemoglobin levels of 7.1gm/dl to 11.9 gm/dl in women & 7.1g/dl - 12.9 g/dl in men and serum ferritin as levels less than 15 μg per L for adults and less than 12 μg/L for children. 3) 12 to 60 years aged both male & female persons, who are healthy and not taking any other regular medication for a chronic condition. 4) Both sexes. 5) The participant is able to read and understand the provided information and has given written consent to participate.

Exclusion criteria

Exclusion criteria: 1) persons suffering from uncontrolled systemic diseases that may cause serious complications. 2) Patients who are too sick for consultation, unable to read patient information sheets, unwilling to take part or not give consent to join the study. 3) Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure, 4) Self-reported immuno-compromised state and Presence of any malignancy. 5) Self-reported suffering from Human Immunodeficiency Virus infection. 6) Already undergoing homoeopathic treatment for chronic disease within the last 6 months.

Design outcomes

Primary

MeasureTime frame
Blood Haemoglobin LevelTimepoint: 3 months

Secondary

MeasureTime frame
Serum Ferritin LevelTimepoint: 3 months;Score of WHO Quality Of life QuestionnaireTimepoint: 3 months

Countries

India

Contacts

Public ContactRakesh Ghosh

Metropolitan Homoeopathic Medical College and Hospital

dr.tanmaysarkar@gmail.com9474744264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026